Literature DB >> 15009428

Restricted cytokine production from mouse peritoneal macrophages in culture in spite of extensive uptake of plasmid DNA.

Kei Yasuda1, Hiroki Kawano, Ikuko Yamane, Yoshiyuki Ogawa, Takaharu Yoshinaga, Makiya Nishikawa, Yoshinobu Takakura.   

Abstract

The production of inflammatory cytokines from macrophages (Mphi), upon stimulation with plasmid DNA (pDNA) containing CpG motifs, is a critical process for DNA-based therapies such as DNA vaccination and gene therapy. We compared Mphi activation, following stimulation with naked pDNA, based on the production of cytokines from cell lines (RAW264.7 and J774A1) and peritoneal Mphis in primary culture. The Mphi cell lines RAW264.7 and J774A1 produced a significant amount of tumour necrosis factor-alpha (TNF-alpha) upon stimulation with naked pDNA and this response required endosomal acidification. On the other hand, peritoneal Mphis (both resident and elicited) in primary culture did not secrete TNF-alpha or interleukin-6, although they contain the mRNA of toll-like receptor-9 (TLR-9) and are able to respond to CpG oligodeoxynucleotides. This unresponsiveness was not a result of impaired cellular uptake of pDNA because the primary cultured Mphis showed a higher uptake of pDNA than the RAW264.7 and J774A1 cell lines. These findings have important implications for Mphi activation by naked pDNA as it has been generally assumed that pDNA that contains CpG motifs is a potent agent for inducing inflammatory cytokines in vivo, based on evidence from in vitro studies using Mphi cell lines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009428      PMCID: PMC1782422          DOI: 10.1111/j.1365-2567.2004.01814.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  43 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 2.  Immune effects and therapeutic applications of CpG motifs in bacterial DNA.

Authors:  A M Krieg; J N Kline
Journal:  Immunopharmacology       Date:  2000-07-25

3.  Role of macrophage lysosomal enzymes in the degradation of nucleosomes of apoptotic cells.

Authors:  C Odaka; T Mizuochi
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

Review 4.  Advances in vaccine adjuvants.

Authors:  M Singh; D O'Hagan
Journal:  Nat Biotechnol       Date:  1999-11       Impact factor: 54.908

5.  Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.

Authors:  S Bauer; C J Kirschning; H Häcker; V Redecke; S Hausmann; S Akira; H Wagner; G B Lipford
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

Review 6.  The actions of bacterial DNA on murine macrophages.

Authors:  D P Sester; K J Stacey; M J Sweet; S J Beasley; S L Cronau; D A Hume
Journal:  J Leukoc Biol       Date:  1999-10       Impact factor: 4.962

7.  An auxiliary mode of apoptotic DNA fragmentation provided by phagocytes.

Authors:  D McIlroy; M Tanaka; H Sakahira; H Fukuyama; M Suzuki; K Yamamura; Y Ohsawa; Y Uchiyama; S Nagata
Journal:  Genes Dev       Date:  2000-03-01       Impact factor: 11.361

8.  Modulation of interleukin-12 synthesis by DNA lacking the CpG motif and present in a mycobacterial cell wall complex.

Authors:  M C Filion; B Filion; S Reader; S Ménard; N C Phillips
Journal:  Cancer Immunol Immunother       Date:  2000-08       Impact factor: 6.968

9.  CpG DNA induces stronger immune responses with less toxicity than other adjuvants.

Authors:  R D Weeratna; M J McCluskie; Y Xu; H L Davis
Journal:  Vaccine       Date:  2000-03-06       Impact factor: 3.641

10.  Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.

Authors:  H Häcker; R M Vabulas; O Takeuchi; K Hoshino; S Akira; H Wagner
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

View more
  6 in total

Review 1.  TLR7 and TLR9 in SLE: when sensing self goes wrong.

Authors:  T Celhar; R Magalhães; A-M Fairhurst
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

2.  DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells.

Authors:  Takaharu Yoshinaga; Kei Yasuda; Yoshiyuki Ogawa; Makiya Nishikawa; Yoshinobu Takakura
Journal:  Immunology       Date:  2006-12-20       Impact factor: 7.397

3.  TLR9 bone marrow chimeric mice define a role for cerebral TNF in neuroprotection induced by CpG preconditioning.

Authors:  Amy E B Packard; Philberta Y Leung; Keri B Vartanian; Susan L Stevens; Frances R Bahjat; Mary P Stenzel-Poore
Journal:  J Cereb Blood Flow Metab       Date:  2012-09-26       Impact factor: 6.200

4.  Electroporation-mediated transfer of plasmids to the lung results in reduced TLR9 signaling and inflammation.

Authors:  R Zhou; J E Norton; N Zhang; D A Dean
Journal:  Gene Ther       Date:  2007-03-08       Impact factor: 5.250

5.  Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain.

Authors:  E Sloane; S Langer; B Jekich; J Mahoney; T Hughes; M Frank; W Seibert; G Huberty; B Coats; J Harrison; D Klinman; S Poole; S Maier; K Johnson; R Chavez; L R Watkins; L Leinwand; E Milligan
Journal:  Gene Ther       Date:  2009-07-02       Impact factor: 5.250

6.  Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast cancer.

Authors:  F Castro; B Leal; A Denny; R Bahar; S Lampkin; R Reddick; S Lu; C Gravekamp
Journal:  Br J Cancer       Date:  2009-09-29       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.